The ROMA score categorizes patients into low-risk or high-risk for ovarian malignancy. Typically, a ROMA score above a certain threshold (which varies by the assay used) indicates a high risk of malignancy, while a score below this threshold suggests a low risk. Clinicians use this information in conjunction with other diagnostic tools to make informed decisions about further testing or treatment.